GB201101128D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB201101128D0
GB201101128D0 GBGB1101128.5A GB201101128A GB201101128D0 GB 201101128 D0 GB201101128 D0 GB 201101128D0 GB 201101128 A GB201101128 A GB 201101128A GB 201101128 D0 GB201101128 D0 GB 201101128D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1101128.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma SA
Original Assignee
UCB Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Pharma SA filed Critical UCB Pharma SA
Priority to GBGB1101128.5A priority Critical patent/GB201101128D0/en
Publication of GB201101128D0 publication Critical patent/GB201101128D0/en
Priority to ARP110103154A priority patent/AR082799A1/en
Priority to PL11755423T priority patent/PL2614061T3/en
Priority to MYPI2013000767A priority patent/MY162396A/en
Priority to MA35807A priority patent/MA34600B1/en
Priority to DK11755423.8T priority patent/DK2614061T3/en
Priority to SI201130542T priority patent/SI2614061T1/en
Priority to JP2013527681A priority patent/JP5820882B2/en
Priority to KR1020137008975A priority patent/KR101880280B1/en
Priority to RS20150538A priority patent/RS54202B1/en
Priority to PT117554238T priority patent/PT2614061E/en
Priority to NZ607966A priority patent/NZ607966A/en
Priority to MEP-2015-120A priority patent/ME02203B/en
Priority to CA2808959A priority patent/CA2808959C/en
Priority to EA201300317A priority patent/EA024162B1/en
Priority to PCT/GB2011/051647 priority patent/WO2012032334A1/en
Priority to SG2013012794A priority patent/SG187924A1/en
Priority to ES11755423.8T priority patent/ES2544289T3/en
Priority to EP20110755423 priority patent/EP2614061B1/en
Priority to CN201180049091.2A priority patent/CN103153996B/en
Priority to AU2011300521A priority patent/AU2011300521B2/en
Priority to MX2013002529A priority patent/MX2013002529A/en
Priority to HUE11755423A priority patent/HUE025223T2/en
Priority to US13/821,294 priority patent/US9029392B2/en
Priority to BR112013004750-0A priority patent/BR112013004750B1/en
Priority to TW100132061A priority patent/TWI510489B/en
Priority to IL224841A priority patent/IL224841A/en
Priority to CL2013000603A priority patent/CL2013000603A1/en
Priority to ZA2013/01751A priority patent/ZA201301751B/en
Priority to CO13056775A priority patent/CO6680717A2/en
Priority to HK13108926.7A priority patent/HK1181754A1/en
Priority to SM201500195T priority patent/SMT201500195B/en
Priority to HRP20150868TT priority patent/HRP20150868T1/en
Priority to CY20151100718T priority patent/CY1116734T1/en
Ceased legal-status Critical Current

Links

GBGB1101128.5A 2010-09-08 2011-01-21 Therapeutic agents Ceased GB201101128D0 (en)

Priority Applications (34)

Application Number Priority Date Filing Date Title
GBGB1101128.5A GB201101128D0 (en) 2011-01-21 2011-01-21 Therapeutic agents
ARP110103154A AR082799A1 (en) 2010-09-08 2011-08-30 DERIVATIVES OF QUINOLINE AND QUINOXALINE AS QUINASE INHIBITORS
BR112013004750-0A BR112013004750B1 (en) 2010-09-08 2011-09-02 QUINOLINE AND QUINOXALINE DERIVATIVES AS KINASE INHIBITORS
SG2013012794A SG187924A1 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
CN201180049091.2A CN103153996B (en) 2010-09-08 2011-09-02 As quinoline and the quinoxaline derivatives of kinase inhibitor
MA35807A MA34600B1 (en) 2010-09-08 2011-09-02 QUINOLINE AND QUINOXALINE DERIVATIVES AS KINASE INHIBITORS
DK11755423.8T DK2614061T3 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
SI201130542T SI2614061T1 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
JP2013527681A JP5820882B2 (en) 2010-09-08 2011-09-02 Quinolines and quinoxaline derivatives as kinase inhibitors
KR1020137008975A KR101880280B1 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
RS20150538A RS54202B1 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
PT117554238T PT2614061E (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
NZ607966A NZ607966A (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
MEP-2015-120A ME02203B (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
CA2808959A CA2808959C (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
EA201300317A EA024162B1 (en) 2010-09-08 2011-09-02 Quinoline derivatives as kinase inhibitors
PCT/GB2011/051647 WO2012032334A1 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
PL11755423T PL2614061T3 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
ES11755423.8T ES2544289T3 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
EP20110755423 EP2614061B1 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
MYPI2013000767A MY162396A (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
AU2011300521A AU2011300521B2 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
MX2013002529A MX2013002529A (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors.
HUE11755423A HUE025223T2 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors
US13/821,294 US9029392B2 (en) 2010-09-08 2011-09-02 Quinoline derivatives as kinase inhibitors
TW100132061A TWI510489B (en) 2010-09-08 2011-09-06 Quinoline and quinoxaline derivatives as kinase inhibitors
IL224841A IL224841A (en) 2010-09-08 2013-02-21 3-(substituted fluoroethyl)-quinoline and -quinoxaline derivatives and pharmaceutical compositions comprising them
CL2013000603A CL2013000603A1 (en) 2010-09-08 2013-03-01 Compounds derived from quinoline and quinoxaline, pi3k inhibitors; pharmaceutical composition that includes them; and its use in the treatment of an inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nocicenoiceptive and ophthalmic disease.
ZA2013/01751A ZA201301751B (en) 2010-09-08 2013-03-07 Quinoline and quinoxaline derivatives as kinase inhibitors
CO13056775A CO6680717A2 (en) 2010-09-08 2013-03-21 Quinoline and quinoxaline derivatives as kinase inhibitors
HK13108926.7A HK1181754A1 (en) 2010-09-08 2013-07-30 Quinoline and quinoxaline derivatives as kinase inhibitors
SM201500195T SMT201500195B (en) 2010-09-08 2015-08-11 Quinoline and quinoxaline derivatives as kinase inhibitors
HRP20150868TT HRP20150868T1 (en) 2010-09-08 2015-08-13 Quinoline and quinoxaline derivatives as kinase inhibitors
CY20151100718T CY1116734T1 (en) 2010-09-08 2015-08-18 KINOLIN AND KINOXALINE DERIVATIVES AS MODELS OF MOTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1101128.5A GB201101128D0 (en) 2011-01-21 2011-01-21 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB201101128D0 true GB201101128D0 (en) 2011-03-09

Family

ID=43769469

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1101128.5A Ceased GB201101128D0 (en) 2010-09-08 2011-01-21 Therapeutic agents

Country Status (1)

Country Link
GB (1) GB201101128D0 (en)

Similar Documents

Publication Publication Date Title
HK1203963A1 (en) Novel therapeutic agents
GB201212513D0 (en) Therapeutic agents
ZA201305897B (en) Combination therapy
GB201114212D0 (en) Therapeutic agents
EP2673286A4 (en) Therapeutic compounds
ZA201400120B (en) Combination therapy
GB201119401D0 (en) Therapeutic agents
EP2740420A4 (en) Therapeutic implement
GB201217704D0 (en) Therapeutic agents
ZA201502595B (en) Therapeutic methods
IL229081A0 (en) Isoxazolines as therapeutic agents
PL2723330T3 (en) Vasoconstrictor-containing agent for combination therapy
EP2701744A4 (en) Combination therapy
EP2688566A4 (en) Anticancer therapeutic agents
SG11201402226PA (en) Therapeutic agent for arthrosis
GB201102913D0 (en) Novel therapeutic
GB201115558D0 (en) Therapeutic agents
GB201110614D0 (en) Therapeutic agents
GB201101128D0 (en) Therapeutic agents
ZA201405764B (en) Novel therapeutic agents
GB201110895D0 (en) Therapeutic use
GB201223021D0 (en) Therapeutic agents
GB201212512D0 (en) Therapeutic agents
GB201210233D0 (en) Therapeutic agents
GB201114226D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)